2592 fundamentals
An in-depth look to CLOUDBREAK PHARMA INC operating, investing, and financing activities
2592 free cash flow for H2 24 is -44.33 M HKD. For 2024, 2592 free cash flow was -192.36 M HKD and operating cash flow was -191.15 M HKD.
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
TTM